RARRES1 and neoplasm: While we previously characterized the role of an atRA-inducible tumor suppressor, RARRES1, in TNBC [41], basal expression of RARRES1 (Figure 2N) and fold-change in expression following atRA treatment (Figure 2O) show no correlation with atRA sensitivity.